Therefore, the present study investigated clinical biomarkers, such as TARC, IgE, eosinophils, type 2 cytokines, and the number of IENFs, using skin biopsies and blood samples from 12 adult Japanese patients with moderate to severe AD before and after a treatment with dupilumab. Here, IGHE is linked to Alzheimer disease.